HUP0201100A3 - Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia and pharmaceutical compositions containing them and their use - Google Patents

Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia and pharmaceutical compositions containing them and their use

Info

Publication number
HUP0201100A3
HUP0201100A3 HU0201100A HUP0201100A HUP0201100A3 HU P0201100 A3 HUP0201100 A3 HU P0201100A3 HU 0201100 A HU0201100 A HU 0201100A HU P0201100 A HUP0201100 A HU P0201100A HU P0201100 A3 HUP0201100 A3 HU P0201100A3
Authority
HU
Hungary
Prior art keywords
glycosaminoglycans
treatment
molecular weight
average molecular
pharmaceutical compositions
Prior art date
Application number
HU0201100A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Cornelli Umberto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornelli Umberto filed Critical Cornelli Umberto
Publication of HUP0201100A2 publication Critical patent/HUP0201100A2/hu
Publication of HUP0201100A3 publication Critical patent/HUP0201100A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
HU0201100A 1999-05-14 2000-05-12 Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia and pharmaceutical compositions containing them and their use HUP0201100A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001066A IT1312107B1 (it) 1999-05-14 1999-05-14 Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile

Publications (2)

Publication Number Publication Date
HUP0201100A2 HUP0201100A2 (hu) 2002-07-29
HUP0201100A3 true HUP0201100A3 (en) 2003-03-28

Family

ID=11382970

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201100A HUP0201100A3 (en) 1999-05-14 2000-05-12 Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia and pharmaceutical compositions containing them and their use

Country Status (22)

Country Link
US (1) US6979680B1 (enExample)
EP (1) EP1181024B1 (enExample)
JP (1) JP2002544233A (enExample)
KR (1) KR100711142B1 (enExample)
CN (1) CN1178667C (enExample)
AT (1) ATE288761T1 (enExample)
AU (1) AU764743C (enExample)
CA (1) CA2373975A1 (enExample)
CZ (1) CZ20014092A3 (enExample)
DE (1) DE60018061T2 (enExample)
DK (1) DK1181024T3 (enExample)
ES (1) ES2237425T3 (enExample)
HK (1) HK1039903B (enExample)
HU (1) HUP0201100A3 (enExample)
IL (1) IL146458A0 (enExample)
IT (1) IT1312107B1 (enExample)
NO (1) NO328902B1 (enExample)
PL (1) PL198016B1 (enExample)
PT (1) PT1181024E (enExample)
RU (1) RU2248800C2 (enExample)
WO (1) WO2000069444A1 (enExample)
ZA (1) ZA200109331B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344781A1 (en) * 2002-03-12 2003-09-17 Laboratori Derivati Organici S.P.A. Process for the depolymerization of glycosaminoglycanes and products obtained therefrom
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
EP1524276A1 (en) * 2003-10-16 2005-04-20 Laboratori Derivati Organici S.P.A. Multistep process for the physical depolymerization of heparin and products obtained therefrom
US7939512B2 (en) 2004-10-13 2011-05-10 Laboratori Derivati Organici Spa Multistep process for the physical depolymerization of heparin and products obtained therefrom
DE602006016990D1 (de) 2005-12-22 2010-10-28 Bellus Health Int Ltd Behandlung von diabetischer nephropathie
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US8896239B2 (en) 2008-05-22 2014-11-25 Vladimir Yegorovich Balakin Charged particle beam injection method and apparatus used in conjunction with a charged particle cancer therapy system
CN102119586B (zh) 2008-05-22 2015-09-02 弗拉迪米尔·叶戈罗维奇·巴拉金 多场带电粒子癌症治疗方法和装置
JP5450602B2 (ja) 2008-05-22 2014-03-26 エゴロヴィチ バラキン、ウラジミール シンクロトロンによって加速された荷電粒子を用いて腫瘍を治療する腫瘍治療装置
EP2283713B1 (en) 2008-05-22 2018-03-28 Vladimir Yegorovich Balakin Multi-axis charged particle cancer therapy apparatus
US8841866B2 (en) 2008-05-22 2014-09-23 Vladimir Yegorovich Balakin Charged particle beam extraction method and apparatus used in conjunction with a charged particle cancer therapy system
SG173879A1 (en) 2009-03-04 2011-10-28 Protom Aozt Multi-field charged particle cancer therapy method and apparatus
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
ES2675993T3 (es) * 2011-10-14 2018-07-16 Centre National De La Recherche Scientifique Procedimiento de diagnóstico, pronóstico o tratamiento de enfermedades neurodegenerativas
CN112426434A (zh) * 2020-11-04 2021-03-02 山东大学 硫酸乙酰肝素在防治阿尔兹海默症中的应用
CN114478816A (zh) * 2022-02-11 2022-05-13 上海兴糖生物技术有限公司 一种白玉蜗牛多糖及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
EP0243974B1 (en) * 1986-05-01 1994-03-02 Toppan Printing Co., Ltd. Scanner set-up simulation apparatus
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
IT1205042B (it) * 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
SK279285B6 (sk) * 1991-05-02 1998-09-09 Daiichi Pharmaceutical Co. Použitie n-(2,6-dimetylfenyl)-2-(2-oxo-1-pyrolidin
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера

Also Published As

Publication number Publication date
NO328902B1 (no) 2010-06-14
DE60018061D1 (de) 2005-03-17
EP1181024A1 (en) 2002-02-27
NO20015544D0 (no) 2001-11-13
CN1178667C (zh) 2004-12-08
HK1039903A1 (en) 2002-05-17
AU4405200A (en) 2000-12-05
HK1039903B (en) 2005-08-26
HUP0201100A2 (hu) 2002-07-29
AU764743B2 (en) 2003-08-28
AU764743C (en) 2004-03-18
CZ20014092A3 (cs) 2002-04-17
PL352070A1 (en) 2003-07-28
PT1181024E (pt) 2005-06-30
CA2373975A1 (en) 2000-11-23
IT1312107B1 (it) 2002-04-04
ATE288761T1 (de) 2005-02-15
ES2237425T3 (es) 2005-08-01
PL198016B1 (pl) 2008-05-30
NO20015544L (no) 2002-01-14
US6979680B1 (en) 2005-12-27
EP1181024B1 (en) 2005-02-09
DK1181024T3 (da) 2005-06-13
CN1350459A (zh) 2002-05-22
DE60018061T2 (de) 2006-04-13
ITMI991066A1 (it) 2000-11-14
KR100711142B1 (ko) 2007-04-24
KR20020005033A (ko) 2002-01-16
JP2002544233A (ja) 2002-12-24
ZA200109331B (en) 2002-08-28
RU2248800C2 (ru) 2005-03-27
IL146458A0 (en) 2002-07-25
WO2000069444A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
HUP0201100A3 (en) Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia and pharmaceutical compositions containing them and their use
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HUP0201409A3 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP0104867A3 (en) Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use
PL356365A1 (en) 4-aminopiperidine derivatives and their use as medicine
IL116486A0 (en) Novel piperidine derivatives processes for their preparation and pharmaceutical compositions containing them
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
HUP0200284A3 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders, process for their preparation and pharmaceutical compositions containing them
PL316528A1 (en) Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disorders
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AP2001002355A0 (en) Derivatives of purine their preparation process and pharmaceutical compositions containing them
ZA9557B (en) Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them
HUP0301030A3 (en) New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
IL123900A0 (en) New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions
IL118427A (en) N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
HUP0203884A3 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0003244A3 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
AU1546101A (en) Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees